Investors in Mirum Pharmaceuticals Inc (Symbol: MIRM) saw new options become available this week, for the March 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Mirum Pharmaceuticals, Inc. (MIRM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

NASDAQ MIRM opened at $47.53 on Friday. The company has a 50-day simple moving average of $43.70 and a two-hundred day simple moving average of $41.45. Mirum Pharmaceuticals has a 12-month low of ...

In other news, COO Peter Radovich sold 1,998 shares of the stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $42.82, for a total transaction ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...